Table 1. Patient and treatment characteristics in patients with and without mutation profiling data.

	Mutation data (N = 78)		No mutation data (N = 112)		p-value (χ2)
	N	%	N	%
Sex					0.40
Female	20	26	35	31
Male	58	74	77	69
Age (years)					0.27
< 60	44	56	54	48
≥ 60	34	44	58	52
Median[range]	57.9 [30.7 ; 88.9]		60.6 [34.4 ; 85.0]
Performance status					0.08
0	38	49	69	62
≥ 1	40	51	43	38
Histology					0.10
Adenocarcinoma	40	51	44	39
Other*	38	49	68	61
T-stage					0.60
T0–T2	35	45	46	41
T3–T4	43	55	66	59
N-stage					0.53
N0–N1	13	17	15	13
N2–N3	65	83	97	87
Stage					0.001
IIIA	47	60	41	37
IIIB	31	40	71	63
Smoking status					0.16
Current smoker	31	40	56	50
Never or former smoker	47	60	56	50
Diabetes					0.04
No	68	87	107	96
Yes	10	13	5	4
Radiotherapy dose					0.78
< 66 Gy	27	35	41	37
≥ 66 Gy	51	65	71	63
Thoracic surgery					0.06
No	60	77	98	87
Yes	18	23	14	13

^*Includes large cell carcinoma, mixed cell carcinoma, neuroendocrine markers, squamous cell carcinoma, undifferentiated tumor.